{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:14:07Z","timestamp":1778602447663,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004241","name":"China Primary Health Care Foundation","doi-asserted-by":"publisher","award":["202"],"award-info":[{"award-number":["202"]}],"id":[{"id":"10.13039\/501100004241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry & Cell Biology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.biocel.2026.106928","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T08:56:00Z","timestamp":1772096160000},"page":"106928","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["EFNA3-mediated autophagy suppression drives breast cancer proliferation, EMT and metastasis via PI3K\/AKT\/mTOR axis"],"prefix":"10.1016","volume":"194","author":[{"given":"Luoqiang","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yupeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenlong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9269-3463","authenticated-orcid":false,"given":"Xihai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.biocel.2026.106928_bib1","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.172366","article-title":"Multiomics of HER2-low triple-negative breast cancer identifies a receptor tyrosine kinase-relevant subgroup with therapeutic prospects","volume":"8","author":"Chen","year":"2023","journal-title":"JCI Insight"},{"issue":"21","key":"10.1016\/j.biocel.2026.106928_bib2","first-page":"7836","article-title":"Targeting autophagy in breast cancer","volume":"21","author":"Cocco","year":"2020"},{"issue":"1","key":"10.1016\/j.biocel.2026.106928_bib3","first-page":"290","article-title":"Inhibition of autophagy by chloroquine prevents resistance to PI3K\/AKT inhibitors and potentiates their antitumor effect in combination with paclitaxel in triple negative breast cancer models","volume":"20","author":"Cocco","year":"2022"},{"issue":"8","key":"10.1016\/j.biocel.2026.106928_bib4","first-page":"560","article-title":"KMJNrMcb. Autophagy and autophagy-related pathways in cancer","volume":"24","author":"Debnath","year":"2023"},{"issue":"1","key":"10.1016\/j.biocel.2026.106928_bib5","first-page":"535","article-title":"EFNA3 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with lung adenocarcinoma","volume":"21","author":"Deng","year":"2021"},{"issue":"1","key":"10.1016\/j.biocel.2026.106928_bib6","first-page":"68","article-title":"CLDN6 inhibits breast cancer metastasis through WIP-dependent actin cytoskeleton-mediated autophagy","volume":"42","author":"Dong","year":"2023"},{"issue":"9","key":"10.1016\/j.biocel.2026.106928_bib7","first-page":"1849","article-title":"Ononin inhibits triple-negative breast cancer lung metastasis by targeting the EGFR-mediated PI3K\/Akt\/mTOR pathway","volume":"67","author":"Ganesan","year":"2024"},{"issue":"1","key":"10.1016\/j.biocel.2026.106928_bib8","first-page":"213","article-title":"Impact of breast cancer surgery on angiogenesis circulating biomarkers: a prospective longitudinal study","volume":"11","author":"Georgiou","year":"2013"},{"issue":"5","key":"10.1016\/j.biocel.2026.106928_bib9","doi-asserted-by":"crossref","first-page":"331","DOI":"10.6004\/jnccn.2024.0035","article-title":"Breast cancer, version 3.2024, NCCN clinical practice guidelines in oncology","volume":"22","author":"Gradishar","year":"2024","journal-title":"J. Natl. Compr. Canc Netw."},{"issue":"7","key":"10.1016\/j.biocel.2026.106928_bib10","first-page":"2847","article-title":"hMAGEA2 accelerates the progression of prostate cancer via the EFNA3\u2013Erk1\/2 signaling pathway","volume":"44","author":"Han","year":"2024"},{"key":"10.1016\/j.biocel.2026.106928_bib11","doi-asserted-by":"crossref","unstructured":"Hao C., Wei Y., Meng W., Zhang J., Yang X.J.Ctr. PI3K\/AKT\/mTOR inhibitors for hormone receptor-positive advanced breast cancer. 2024:102861.","DOI":"10.1016\/j.ctrv.2024.102861"},{"key":"10.1016\/j.biocel.2026.106928_bib12","article-title":"EMT mechanism in breast cancer metastasis and drug resistance: revisiting molecular interactions and biological functions","volume":"155","author":"Hashemi","year":"2022"},{"issue":"1","key":"10.1016\/j.biocel.2026.106928_bib13","first-page":"131","article-title":"JJJoH, Oncology. Current and future immunotherapy for breast cancer","volume":"17","author":"Heater","year":"2024"},{"issue":"2","key":"10.1016\/j.biocel.2026.106928_bib14","first-page":"383","article-title":"Ephrin-A3\/EphA2 axis regulates cellular metabolic plasticity to enhance cancer stemness in hypoxic hepatocellular carcinoma","volume":"77","author":"Husain","year":"2022"},{"issue":"4","key":"10.1016\/j.biocel.2026.106928_bib15","first-page":"8995","article-title":"LncRNA LINC01270 aggravates the progression of gastric cancer through modulation of miR-326\/EFNA3 axis","volume":"13","author":"Jiang","year":"2022"},{"issue":"1","key":"10.1016\/j.biocel.2026.106928_bib16","first-page":"137","article-title":"Deep learning applications in breast cancer histopathological imaging: diagnosis, treatment, and prognosis","volume":"26","author":"Jiang","year":"2024"},{"issue":"8","key":"10.1016\/j.biocel.2026.106928_bib17","first-page":"1038","article-title":"Wedelolactone suppresses breast cancer growth and metastasis via regulating TGF-\u03b21\/Smad signaling pathway","volume":"76","author":"Li","year":"2024"},{"issue":"1","key":"10.1016\/j.biocel.2026.106928_bib18","first-page":"324","article-title":"TRPV2 calcium channel promotes breast cancer progression potential by activating autophagy","volume":"24","author":"Li","year":"2024"},{"key":"10.1016\/j.biocel.2026.106928_bib19","article-title":"Synthesis and evaluation of novel HER-2 inhibitors to exert anti-breast cancer ability through epithelial-mesenchymal transition (EMT) pathway","volume":"237","author":"Li","year":"2022"},{"issue":"3","key":"10.1016\/j.biocel.2026.106928_bib20","first-page":"879","article-title":"HJJoH. EFNA3 is a prognostic biomarker for the overall survival of patients with hepatocellular carcinoma","volume":"77","author":"Lin","year":"2022"},{"issue":"9","key":"10.1016\/j.biocel.2026.106928_bib21","first-page":"2511","article-title":"Rapamycin prevents spontaneous abortion by triggering decidual stromal cell autophagy-mediated NK cell residence","volume":"17","author":"Lu","year":"2021"},{"issue":"2","key":"10.1016\/j.biocel.2026.106928_bib22","first-page":"442","article-title":"Y-QJJoIS. Expression of CDK13 was associated with prognosis and expression of HIF-1\u03b1 and beclin1 in breast cancer patients","volume":"35","author":"Lu","year":"2022"},{"issue":"7","key":"10.1016\/j.biocel.2026.106928_bib23","first-page":"1402","article-title":"Unlocking overexpressed membrane proteins to guide breast cancer precision medicine","volume":"16","author":"Mendon\u00e7a","year":"2024"},{"issue":"5","key":"10.1016\/j.biocel.2026.106928_bib24","first-page":"558","article-title":"EphA2 promotes infiltrative invasion of glioma stem cells in vivo through cross-talk with Akt and regulates stem cell properties","volume":"34","author":"Miao","year":"2015"},{"key":"10.1016\/j.biocel.2026.106928_bib25","article-title":"CJFio. PI3K\/Akt\/mTOR pathway and its role in cancer therapeutics: are we making headway?","volume":"12","author":"Peng","year":"2022"},{"issue":"10","key":"10.1016\/j.biocel.2026.106928_bib26","article-title":"Promising and challenging phytochemicals targeting LC3 mediated autophagy signaling in cancer therapy","volume":"12","author":"Rajendran","year":"2024"},{"issue":"6","key":"10.1016\/j.biocel.2026.106928_bib27","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.1007\/s11357-024-01187-z","article-title":"Everolimus alleviates CD4(+) T cell inflammation by regulating autophagy and cellular redox homeostasis","volume":"46","author":"Rockhold","year":"2024","journal-title":"Geroscience"},{"issue":"2","key":"10.1016\/j.biocel.2026.106928_bib28","first-page":"522","article-title":"Expression profiling of the ephrin (EFN) and Eph receptor (EPH) family of genes in atherosclerosis-related human cells","volume":"39","author":"Sakamoto","year":"2011"},{"issue":"15","key":"10.1016\/j.biocel.2026.106928_bib29","first-page":"12173","article-title":"S-TJIJoMS. Knockdown of PTK7 reduces the oncogenic potential of breast cancer cells by impeding receptor tyrosine kinase signaling","volume":"24","author":"Shin","year":"2023"},{"issue":"11","key":"10.1016\/j.biocel.2026.106928_bib30","first-page":"9419","article-title":"MJJoBC. Specific and shared targets of ephrin A signaling in epidermal keratinocytes","volume":"286","author":"Walsh","year":"2011"},{"key":"10.1016\/j.biocel.2026.106928_bib31","article-title":"Silencing of KIF3B suppresses breast cancer progression by regulating EMT and Wnt\/\u03b2-catenin signaling","volume":"10","author":"Wang","year":"2021"},{"issue":"5","key":"10.1016\/j.biocel.2026.106928_bib32","first-page":"2442","article-title":"Cisplatin prevents breast cancer metastasis through blocking early EMT and retards cancer growth together with paclitaxel","volume":"11","author":"Wang","year":"2021"},{"issue":"21","key":"10.1016\/j.biocel.2026.106928_bib33","first-page":"2376","article-title":"Maternal and embryonic signals cause functional differentiation of luminal epithelial cells and receptivity establishment","volume":"58","author":"Wang","year":"2023"},{"issue":"16","key":"10.1016\/j.biocel.2026.106928_bib34","first-page":"5462","article-title":"QJJoC. Autophagy modulation in therapeutic strategy of breast cancer drug resistance","volume":"15","author":"Wang","year":"2024"},{"issue":"5","key":"10.1016\/j.biocel.2026.106928_bib35","article-title":"Tumor-suppressor function of Beclin 1 in breast cancer cells requires E-cadherin","volume":"118","author":"Wijshake","year":"2021"},{"issue":"8","key":"10.1016\/j.biocel.2026.106928_bib36","first-page":"1156","article-title":"Autophagy and breast cancer: connected in growth, progression, and therapy","volume":"12","author":"Wu","year":"2023"},{"issue":"1","key":"10.1016\/j.biocel.2026.106928_bib37","first-page":"49","article-title":"Breast cancer: pathogenesis and treatments","volume":"10","author":"Xiong","year":"2025"},{"issue":"1","key":"10.1016\/j.biocel.2026.106928_bib38","first-page":"467","article-title":"Identifying tumor cell-released extracellular vesicles as biomarkers for breast cancer diagnosis by a three-dimensional hydrogel-based electrochemical immunosensor","volume":"21","author":"Zhang","year":"2023"},{"key":"10.1016\/j.biocel.2026.106928_bib39","article-title":"EFNA3 is a prognostic biomarker correlated with immune cell infiltration and immune checkpoints in gastric cancer","volume":"12","author":"Zheng","year":"2022"},{"issue":"16","key":"10.1016\/j.biocel.2026.106928_bib40","first-page":"2508","article-title":"PI3K\/AKT\/mTOR-targeted therapy for breast cancer","volume":"11","author":"Zhu","year":"2022"}],"container-title":["The International Journal of Biochemistry & Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272526000324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272526000324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:43:05Z","timestamp":1778600585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272526000324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":40,"alternative-id":["S1357272526000324"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2026.106928","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EFNA3-mediated autophagy suppression drives breast cancer proliferation, EMT and metastasis via PI3K\/AKT\/mTOR axis","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2026.106928","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106928"}}